Tecar Therapy in Chronic Knee Osteoarthritis
Effects of Tecar Therapy (Targeted Radiofrequency Therapy) on Pain, Physical Function, and Physical Capacity in Patients With Chronic Knee Osteoarthritis: A Randomized Controlled Trial
1 other identifier
interventional
60
1 country
1
Brief Summary
This study aimed to investigate the effects of Tecar therapy on pain, physical function, and physical capacity in patients with chronic knee osteoarthritis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 23, 2026
CompletedFirst Posted
Study publicly available on registry
February 27, 2026
CompletedStudy Start
First participant enrolled
April 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
March 2, 2026
February 1, 2026
3 months
February 23, 2026
February 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Visual Analog Scale
VAS is a pain rating scale with numbers 0 and 10. Here 0 means 'no pain' and 10 means 'unbearable pain'. The participant will rate the pain according to the scale. Patients' night, rest and activity pain will be evaluated separately.
baseline, 3th week, 12th week
Secondary Outcomes (2)
WOMAC
baseline, 3th week, 12th week
The 6-minute walk test (6MWT)
baseline, 3th week, 12th week
Study Arms (3)
Tecar theraphy
EXPERIMENTALConventional physical therapy and Tecar therapy: Conventional physiotherapy will include 15 sessions of TENS (100 Hz frequency, 10-30 mA intensity) and Hotpack therapy for all groups, 5 sessions per week over 3 weeks. A heating pad will be applied to the painful knee area for 20 minutes to provide superficial heat, followed by 20 minutes of TENS at 100 Hz using an HP or Chattanooga device. Simultaneously, all groups will receive knee isometric and Theraband exercise therapy under the supervision of a physiotherapist. This group will also receive TECAR therapy three times a week for three weeks, a total of nine sessions, at 0.5 MHz frequency, in a 5 min CAP + 10 min RES + 5 min CAP mode, administered by an experienced physiotherapist.
Sham tecar theraphy
EXPERIMENTALConventional physical therapy and sham Tecar therapy: Conventional physiotherapy will include 15 sessions of TENS (100 Hz frequency, 10-30 mA intensity) and Hotpack therapy for all groups, 5 sessions per week over 3 weeks. A heating pad will be applied to the painful knee area for 20 minutes to provide superficial heat, followed by 20 minutes of TENS at 100 Hz using an HP or Chattanooga device. Simultaneously, all groups will receive knee isometric and Theraband exercise therapy under the supervision of a physiotherapist. This group will also receive TECAR sham therapy three times a week for three weeks, a total of nine sessions, at 0.5 MHz frequency, in a 5 min CAP + 10 min RES + 5 min CAP mode, administered by an experienced physiotherapist. The gel will be applied before the device is activated.
conventional physiotherapy
EXPERIMENTALConventional FTR: Conventional physical therapy will include 15 sessions of TENS (100 Hz frequency, 10-30 mA intensity) and Hotpack therapy for all groups, 5 sessions per week over 3 weeks. A heating pad will be applied to the painful knee area for 20 minutes to provide superficial heat, followed by 20 minutes of TENS at 100 Hz using an HP or Chattanooga device. Simultaneously, all groups will receive knee isometric and Theraband exercise therapy under the supervision of a physiotherapist.
Interventions
conventional physical therapy
Eligibility Criteria
You may qualify if:
- Patients with Kellgren-Lawrence stage 2 or 3 knee osteoarthritis
- Patients with bilateral knee pain for at least 6 weeks
- Male and female patients aged 40-75
- Patients who accept and sign the informed consent form
You may not qualify if:
- Those who have received physical therapy for knee pain in the last 6 months
- Those who have received intraarticular injection treatments such as hyaluronic acid, PRP, or steroids for knee pain in the last 6 months
- Those who have undergone knee surgery for any reason
- Those with inflammatory arthritis
- Those with existing neurological, cognitive, or psychiatric disorders
- Those with pacemakers
- Those with a history of malignancy
- Those with local vascular or sensory impairment
- Those with local or systemic infections
- Those with open wounds on the skin
- Pregnant or breastfeeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kırşehir Ahi Evran Üniversitesi
Kırşehir, Kırşehir, Turkey (Türkiye)
Related Publications (2)
Coccetta CA, Sale P, Ferrara PE, Specchia A, Maccauro G, Ferriero G, Ronconi G. Effects of capacitive and resistive electric transfer therapy in patients with knee osteoarthritis: a randomized controlled trial. Int J Rehabil Res. 2019 Jun;42(2):106-111. doi: 10.1097/MRR.0000000000000324.
PMID: 30362981BACKGROUNDElboim-Gabyzon M, Nahhas F. Laser therapy versus pulsed electromagnetic field therapy as treatment modalities for early knee osteoarthritis: a randomized controlled trial. BMC Geriatr. 2023 Mar 16;23(1):144. doi: 10.1186/s12877-022-03568-5.
PMID: 36922781BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Asst. Prof.
Study Record Dates
First Submitted
February 23, 2026
First Posted
February 27, 2026
Study Start
April 1, 2026
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
August 1, 2026
Last Updated
March 2, 2026
Record last verified: 2026-02